RJRishabh Jain

Rishabh Jain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rishabh Jain has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Using Chemoattractants to Lure Bacteria to Contact‐Killing Surfaces

    by Rishabh Jain, Nancy G. Faith, Andrew Milkowski, Kevin Nelson, David Busche, David M. Lynn, Charles J. Czuprynski, Nicholas L. Abbott

    Antimicrobial surfaces with covalently attached biocidal functionalities only kill microbes that come into direct contact with the surfaces (contact‐killing surfaces). Herein, the activity of contact‐killing surfaces is shown to be enhanced by using gradients in the concentration of soluble chemoattractants (CAs) to attract bacteria to the surfaces. Two natural and nonbiocidal CAs (aspartate and glucose) were used to attract bacteria to model surfaces decorated with quaternary ammonium groups (known to kill bacteria that come into contact with them). These results demonstrate the killing of Escherichia coli and Salmonella typhimurium, two common pathogens, at levels 10‐ to 20‐times greater than that of the native surfaces alone. This approach is general and provides new strategies for the design of active or dynamic contact‐killing surfaces with enhanced antimicrobial activities.


  • Open Access

    Raman Spectroscopy Enables Noninvasive Biochemical Characterization and Identification of the Stage of Healing of a Wound

    by Rishabh Jain, Diego Calderon, Patricia R. Kierski, Michael J. Schurr, Charles J. Czuprynski, Christopher J. Murphy, Jonathan F. McAnulty, Nicholas L. Abbott

    Accurate and rapid assessment of the healing status of a wound in a simple and noninvasive manner would enable clinicians to diagnose wounds in real time and promptly adjust treatments to hasten the resolution of nonhealing wounds. Histologic and biochemical characterization of biopsied wound tissue, which is currently the only reliable method for wound assessment, is invasive, complex to interpret, and slow. Here we demonstrate the use of Raman microspectroscopy coupled with multivariate spectral analysis as a simple, noninvasive method to biochemically characterize healing wounds in mice and to accurately identify different phases of healing of wounds at different time-points. Raman spectra were collected from “splinted” full thickness dermal wounds in mice at 4 time-points (0, 1, 5, and 7 days) corresponding to different phases of wound healing, as verified by histopathology. Spectra were deconvolved using multivariate factor analysis (MFA) into 3 “factor score spectra” (that act as spectral signatures for different stages of healing) that were successfully correlated with spectra of prominent pure wound bed constituents (i.e., collagen, lipids, fibrin, fibronectin, etc.) using non-negative least squares (NNLS) fitting. We show that the factor loadings (weights) of spectra that belonged to wounds at different time-points provide a quantitative measure of wound healing progress in terms of key parameters such as inflammation and granulation. Wounds at similar stages of healing were characterized by clusters of loading values and slowly healing wounds among them were successfully identified as “outliers”. Overall, our results demonstrate that Raman spectroscopy can be used as a noninvasive technique to provide insight into the status of normally healing and slow-to-heal wounds and that it may find use as a complementary tool for real-time, in situ biochemical characterization in wound healing studies and clinical diagnosis.


  • The use of native chemical functional groups presented by wound beds for the covalent attachment of polymeric microcarriers of bioactive factors

    by Rishabh Jain, Ankit Agarwal, Patricia R. Kierski, Michael J. Schurr, Christopher J. Murphy, Jonathan F. McAnulty, Nicholas L. Abbott


  • Specific Inhibition of the Aspartate Aminotransferase of Plasmodium falciparum

    by Carsten Wrenger, Ingrid B. Müller, Anna J. Schifferdecker, Rishabh Jain, Rositsa Jordanova, Matthew R. Groves


  • Purification, crystallization and preliminary X-ray analysis of the aspartate aminotransferase ofPlasmodium falciparum

    by Rishabh Jain, Rositsa Jordanova, Ingrid B. Müller, Carsten Wrenger, Matthew R. Groves

    Aspartate aminotransferases (EC 2.6.1.1) catalyse the conversion of aspartate and -ketoglutarate to oxaloacetate and glutamate in a reversible manner. Thus, the aspartate aminotransferase of Plasmodium falciparum (PfAspAT) plays a central role in the transamination of amino acids. Recent findings suggest that PfAspAT may also play a pivotal role in energy metabolism and the de novo biosynthesis of pyrimidines. While therapeutics based upon the inhibition of other proteins in these pathways are already used in the treatment of malaria, the advent of multidrug-resistant strains has limited their efficacy. The presence of PfAspAT in these pathways may offer additional opportunities for the development of novel therapeutics. In order to gain a deeper understanding of the function and role of PfAspAT, it has been expressed and purified to homogeneity. The successful crystallization of PfAspAT, the collection of a 2.8 Å diffraction data set and initial attempts to solve the structure using molecular replacement are reported.